NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Crocs, Inc. common stock between November 3, 2022, and October 28, 2024, of the March 24, 2025, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Crocs common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by March 24, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that Crocs failed to disclose critical information regarding the sustainability of HEYDUDE's revenue growth and the impact of destocking by retail partners on Crocs' financial results [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly in securities class action settlements since 2013 [3]

NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nextracker Inc. common stock during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Nextracker common stock between February 1, 2024, and August 1, 2024, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 25, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Nextracker - The lawsuit alleges that Nextracker made false and misleading statements regarding the impact of project delays on its business and financial results [5]. - Specific claims include that permitting and interconnection delays severely impaired Nextracker's ability to convert backlog into revenue, and that the company could not offset negative impacts from these delays as previously claimed [5]. - The lawsuit asserts that Nextracker lacked the competitive advantages it claimed, leading to a lack of reasonable basis for its positive statements about its business prospects [5].

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2025. SO WHAT: If you purchased ESSA Pharma Inc. securities during the Class ...

Core Viewpoint - A class action lawsuit has been filed against Grocery Outlet Holding Corp. for allegedly providing misleading information regarding its transition to new systems, which may have impacted its profitability during the Class Period from November 7, 2023, to May 7, 2024 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Grocery Outlet made overwhelmingly positive statements while concealing material adverse facts about its operational transition, leading to investor damages when the truth was revealed [5]. - Investors who purchased Grocery Outlet securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Representation - The Rosen Law Firm, known for its success in securities class actions, is encouraging investors to select qualified counsel with a proven track record [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6]. Group 3: Class Certification - No class has been certified yet, meaning investors are not represented by counsel unless they retain one [7]. - Investors have the option to remain absent class members and are not required to serve as lead plaintiffs to share in any potential recovery [7].

NEW YORK, Feb. 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2025. SO WHAT: If you purchased Novo Nordisk securities during the Class Per ...

CS Disco (LAW) shares soared 9.3% in the last trading session to close at $5.43. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 0.2% loss over the past four weeks.CS Disco is benefiting from strong customer engagement, strategic leadership hires, and enhanced product offerings, particularly in eDiscovery and AI capabilities.This legal technology company is expected to post quarterly loss of $0.11 per share in its upcoming report ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Crocs, Inc. common stock during the specified Class Period, alleging that the company failed to disclose critical information regarding its revenue growth and financial performance [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to Crocs, Inc. common stock purchases made between November 3, 2022, and October 28, 2024 [1]. - The lawsuit claims that Crocs misled investors about the sustainability of HEYDUDE's revenue growth, attributing it to excess inventory stocking rather than genuine demand [5]. - It is alleged that as retail partners began to destock, the demand for Crocs products declined, negatively impacting financial results [5]. Group 2: Investor Information - Investors who purchased Crocs stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff is needed to represent the class, and interested parties must act by March 24, 2025 [1][3]. Group 3: Rosen Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [4].

NEW YORK, Jan. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities, including call options, of Five9, Inc. (NASDAQ: FIVN) between June 4, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Five9 securities or call options during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a ...